Sarepta Therapeutics Inc (0L35)
LSE
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -76.593 | -5.853 | -24.536 | -41.275 | -23.052 | -13.657 | -22.417 | -16.768 |
Return on Equity (%) | -101.422 | -9.004 | -39.739 | -77.286 | -70.145 | -49.567 | -107.161 | -86.15 |
Return on Invested Capital (%) | -98.921 | -22.481 | -26.603 | -52.812 | -39.208 | -27.92 | -32.627 | -16.189 |
Operating Margin (%) | -4920.31 | -27.718 | -109.257 | -179.399 | -91.301 | -50.638 | -68.243 | -40.061 |
Net Profit Margin (%) | -4930.179 | -32.79 | -120.225 | -187.766 | -102.597 | -59.665 | -75.4 | -43.108 |
Book Value Per Share | 6.001 | 11.959 | 14.362 | 10.716 | 9.425 | 10.488 | 4.291 | 8.87 |
Earnings Per Share | -4.881 | -0.782 | -5.092 | -9.511 | -6.981 | -4.807 | -7.999 | -5.729 |
Cash Per Share | 2.236 | 9.256 | 5.218 | 11.107 | 18.931 | 24.285 | 10.992 | 4.58 |
Working Capital Per Share | 5.443 | 17.6 | 17.623 | 16.016 | 26.069 | 24.692 | 22.038 | 20.585 |
Operating Profit Per Share | 0.097 | 2.272 | 3.755 | 4.313 | 6.006 | 6.942 | 9.017 | 11.684 |
EBIT Per Share | -4.881 | -0.751 | -5.102 | -9.495 | -6.968 | -4.808 | -7.845 | -5.56 |
EBITDA Per Share | -4.881 | -0.751 | -5.102 | -9.495 | -6.968 | -4.808 | -7.845 | -5.56 |
Free Cash Flow Per Share | -4.858 | -0.58 | -4.352 | -8.997 | -6.279 | -4.8 | -8.124 | -5.287 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 54,76M | 64,79M | 71,07M | 75,19M | 79,37M | 87,13M | 87,95M | N/A |
Capitalisation boursière | 8,5B |
Ratio cours/bénéfice | -21,22 |
Ratio prix/ventes | 9,15 |
Ratio prix/liquidités | 26,54 |
Ratio prix/valeur comptable | 13,23 |
Rendement de dividende | - |
Actions en circulation | 93,55M |
Volume moyen (1 semaine) | 26 |
Volume moyen (1 mois) | 873 |
Variation sur 52 semaines | 0,00% |
Plus haut sur 52 semaines | 90,83 |
Plus bas sur 52 semaines | 90,83 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales